BackenVVeno Medical Overview

enVVeno Medical Operating Income

Latest operating income for NVNO: $-17M.

Get informed when a big investor buys or sells

+ Follow

Quarterly Operating Income

$-3796000.00
↓ 46.15% YoY

As of Jun 30, 2026

Annual Operating Income (TTM)

$-16754000.00
↓ 32.64% YoY

Trailing 12 months ending Jun 30, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

enVVeno Medical (NVNO) FAQ

As of the most recent data (June 2026), NVNO shows a operating income of $-17M. That compares with $-25M in the prior-year period — up 32.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NVNO's operating income is now $-17M (was $-25M) — a 32.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether enVVeno Medical is outperforming or lagging.

Tracking NVNO's operating income over time shows whether enVVeno Medical is scaling, shrinking, or reshaping that part of the business. The current reading is $-17M That compares with $-25M in the prior-year period — up 32.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has enVVeno Medical's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-17M) with ownership activity and broader fundamentals.

enVVeno Medical's operating income is $-17M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.